BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1438@pharmaconomics
DTSTAMP:20260707T020126Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:CLLS AdCom — cema-cel (estimated date)
DESCRIPTION:An FDA advisory committee reviews cema-cel for first-line consolidation for large B-cell lymphoma (LBCL) around ~ Jun 30\, 2027. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1627281/000117184326003248/exh_991.htm\n\nTrack it: https://pharmaconomics.com/e/1438
URL:https://pharmaconomics.com/e/1438
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CLLS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR